Track market-moving stories before they get noisy

Posted by Defense World Staff on Jul 21st, 2026

AlTi Global Inc. purchased a new position in Enterprise Products Partners L.P. (NYSE:EPD – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 23,465 shares of the oil and gas producer’s stock, valued at approximately $888,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Alps Advisors Inc. grew its holdings in Enterprise Products Partners by 0.6% in the 4th quarter. Alps Advisors Inc. now owns 42,639,131 shares of the oil and gas producer’s stock valued at $1,367,011,000 after buying an additional 260,305 shares in the last quarter. Auto Owners Insurance Co grew its holdings in shares of Enterprise Products Partners by 3,106.0% in the fourth quarter. Auto Owners Insurance Co now owns 32,060,000 shares of the oil and gas producer’s stock valued at $102,784,000 after purchasing an additional 31,060,000 shares during the period. Morgan Stanley increased its position in Enterprise Products Partners by 4.8% during the fourth quarter. Morgan Stanley now owns 19,116,333 shares of the oil and gas producer’s stock worth $612,870,000 after purchasing an additional 883,983 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in Enterprise Products Partners by 12.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 18,163,343 shares of the oil and gas producer’s stock worth $582,317,000 after purchasing an additional 1,940,583 shares during the period. Finally, Energy Income Partners LLC raised its stake in Enterprise Products Partners by 0.6% during the third quarter. Energy Income Partners LLC now owns 14,705,122 shares of the oil and gas producer’s stock worth $459,829,000 after purchasing an additional 80,884 shares during the period. 26.07% of the stock is currently owned by institutional investors and hedge funds.

Enterprise Products Partners Trading Up 1.4% Shares of NYSE EPD opened at $38.75 on Tuesday. The company has a current ratio of 0.91, a quick ratio of 0.61 and a debt-to-equity ratio of 1.03. The stock has a market capitalization of $83.76 billion, a PE ratio of 14.35, a PEG ratio of 1.37 and a beta of 0.49. Enterprise Products Partners L.P. has a twelve month low of $30.01 and a twelve month high of $40.17. The stock has a fifty day simple moving average of $37.67 and a 200-day simple moving average of $36.59.

Enterprise Products Partners (NYSE:EPD – Get Free Report) last announced its earnings results on Monday, April 27th. The oil and gas producer reported $0.68 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.03). The firm had revenue of $14.39 billion for the quarter, compared to analysts’ expectations of $13.62 billion. Enterprise Products Partners had a net margin of 11.45% and a return on equity of 19.53%. The business’s revenue was down 6.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.64 earnings per share. On average, equities analysts forecast that Enterprise Products Partners L.P. will post 2.97 earnings per share for the current year.

Enterprise Products Partners Increases Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 31st will be issued a $0.56 dividend. This represents a $2.24 dividend on an annualized basis and a dividend yield of 5.8%. This is an increase from Enterprise Products Partners’s previous quarterly dividend of $0.55. The ex-dividend date is Friday, July 31st. Enterprise Products Partners’s dividend payout ratio (DPR) is presently 81.48%.

Wall Street Analyst Weigh In Several research firms have recently weighed in on EPD. Citigroup reissued a “buy” rating and issued a $44.00 price target (up from $39.00) on shares of Enterprise Products Partners in a research note on Friday, May 1st. Wells Fargo & Company upgraded Enterprise Products Partners from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $40.00 to $42.00 in a report on Wednesday, March 25th. Royal Bank Of Canada raised their target price on Enterprise Products Partners from $40.00 to $42.00 and gave the stock an “outperform” rating in a research note on Monday, March 30th. Weiss Ratings downgraded Enterprise Products Partners from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, July 2nd. Finally, Scotiabank reaffirmed a “sector perform” rating and issued a $40.00 price target (up from $39.00) on shares of Enterprise Products Partners in a research note on Tuesday, May 12th. Eight equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Enterprise Products Partners has a consensus rating of “Hold” and a consensus target price of $40.13.

View Our Latest Stock Report on EPD

Enterprise Products Partners Company Profile (Free Report)

Enterprise Products Partners L.P. (NYSE: EPD) is a Houston-based master limited partnership that provides midstream energy services across North America. The company owns and operates an extensive network of pipelines, storage facilities, processing plants and export terminals that transport and handle natural gas, natural gas liquids (NGLs), crude oil and refined and petrochemical products. Its core activities include gathering and transportation, fractionation of NGLs, natural gas processing, crude oil and condensate pipelines, and marine and terminal services that enable domestic distribution and exports.

Enterprise serves a diverse set of customers including producers, refiners, petrochemical companies, marketers and end users.

See Also Five stocks we like better than Enterprise Products Partners The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Enterprise Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enterprise Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmova Asset Management Americas Inc. Has $376.07 Million Stake in Tesla, Inc. $TSLA

NEXT HEADLINE »AlTi Global Inc. Has $1.60 Million Stock Position in Taiwan Semiconductor Manufacturing Company Ltd. $TSM

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. reduced its position in Natera, Inc. (NASDAQ:NTRA – Free Report) by 10.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 423,424 shares of the medical research company’s stock after selling 47,660 shares during the quarter. Natera makes up 1.2% of Amova Asset Management Americas Inc.’s portfolio, making the stock its 29th largest holding. Amova Asset Management Americas Inc. owned approximately 0.30% of Natera worth $84,685,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Robinhood Asset Management LLC bought a new position in Natera in the fourth quarter valued at $12,981,000. Systrade AG acquired a new stake in Natera in the 4th quarter valued at $11,454,000. J. Safra Sarasin Holding AG bought a new stake in Natera during the 4th quarter worth about $2,825,000. UBS Group AG boosted its stake in shares of Natera by 19.4% during the 4th quarter. UBS Group AG now owns 438,857 shares of the medical research company’s stock worth $100,538,000 after buying an additional 71,355 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its stake in shares of Natera by 25.9% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 45,835 shares of the medical research company’s stock worth $11,476,000 after buying an additional 9,424 shares during the last quarter. Institutional investors own 99.90% of the company’s stock.

Analyst Upgrades and Downgrades A number of research firms recently issued reports on NTRA. Barclays lowered their target price on Natera from $280.00 to $260.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 24th. Guggenheim raised their price target on Natera from $270.00 to $290.00 and gave the company a “buy” rating in a research note on Monday, June 29th. Evercore reaffirmed an “outperform” rating and set a $300.00 price target on shares of Natera in a research report on Monday, July 6th. Piper Sandler reiterated an “overweight” rating and set a $249.00 price objective on shares of Natera in a research note on Tuesday, May 12th. Finally, Wall Street Zen downgraded Natera from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Three research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Natera currently has a consensus rating of “Moderate Buy” and a consensus target price of $267.83.

Check Out Our Latest Stock Analysis on Natera

Natera Stock Performance NASDAQ:NTRA opened at $262.63 on Tuesday. Natera, Inc. has a 52 week low of $131.81 and a 52 week high of $288.04. The firm’s 50-day simple moving average is $235.24 and its 200 day simple moving average is $220.56. The firm has a market cap of $37.61 billion, a price-to-earnings ratio of -161.12 and a beta of 1.51.

Insider Activity at Natera In related news, Director Roelof Botha sold 78,000 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $220.31, for a total transaction of $17,184,180.00. Following the sale, the director owned 1,076,198 shares of the company’s stock, valued at $237,097,181.38. This represents a 6.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Solomon Moshkevich sold 3,405 shares of the firm’s stock in a transaction on Friday, May 1st. The stock was sold at an average price of $203.69, for a total value of $693,564.45. Following the transaction, the insider owned 142,295 shares in the company, valued at approximately $28,984,068.55. This trade represents a 2.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 178,872 shares of company stock valued at $39,627,696. 5.05% of the stock is currently owned by company insiders.

Natera Company Profile (Free Report)

Natera is a global diagnostics company that develops and commercializes cell-free DNA and other genetic testing technologies for clinical applications. The company focuses on three principal areas: reproductive health (including non-invasive prenatal testing and carrier screening), oncology (tumor-informed assays for minimal residual disease and recurrence monitoring), and organ transplantation (cell-free DNA tests to detect allograft injury). Natera combines laboratory testing, proprietary bioinformatics, and clinical reporting to deliver personalized genetic information to clinicians and patients.

Key product offerings include Panorama, a non-invasive prenatal test that screens for fetal chromosomal abnormalities and select single-gene conditions; Horizon carrier screening for inherited conditions; Signatera, a personalized, tumor-informed assay used for detecting minimal residual disease and monitoring treatment response in cancer patients; and Prospera, a donor-derived cell-free DNA test used to assess the risk of organ rejection.

Read More Five stocks we like better than Natera The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding NTRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natera, Inc. (NASDAQ:NTRA – Free Report).

Receive News & Ratings for Natera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAlTi Global Inc. Makes New Investment in Church & Dwight Co., Inc. $CHD

NEXT HEADLINE »Amova Asset Management Americas Inc. Has $87 Million Stake in CoreWeave Inc. $CRWV

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. lifted its position in AeroVironment, Inc. (NASDAQ:AVAV – Free Report) by 10.6% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 221,095 shares of the aerospace company’s stock after buying an additional 21,271 shares during the period. Amova Asset Management Americas Inc. owned approximately 0.44% of AeroVironment worth $40,469,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of AVAV. Geode Capital Management LLC increased its position in shares of AeroVironment by 8.8% during the fourth quarter. Geode Capital Management LLC now owns 884,395 shares of the aerospace company’s stock worth $213,956,000 after purchasing an additional 71,903 shares in the last quarter. Heard Capital LLC increased its position in AeroVironment by 48.4% during the 4th quarter. Heard Capital LLC now owns 722,150 shares of the aerospace company’s stock valued at $174,681,000 after buying an additional 235,685 shares in the last quarter. Ameriprise Financial Inc. raised its stake in AeroVironment by 17.2% in the second quarter. Ameriprise Financial Inc. now owns 504,270 shares of the aerospace company’s stock valued at $143,692,000 after buying an additional 73,963 shares during the last quarter. Stephens Investment Management Group LLC raised its stake in AeroVironment by 18.8% in the first quarter. Stephens Investment Management Group LLC now owns 490,426 shares of the aerospace company’s stock valued at $89,772,000 after buying an additional 77,619 shares during the last quarter. Finally, Alliancebernstein L.P. boosted its holdings in AeroVironment by 7.4% in the second quarter. Alliancebernstein L.P. now owns 477,055 shares of the aerospace company’s stock worth $135,937,000 after acquiring an additional 32,721 shares in the last quarter. Institutional investors own 86.38% of the company’s stock.

Insider Buying and Selling In other AeroVironment news, Director Stephen F. Page sold 250 shares of the stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $174.41, for a total transaction of $43,602.50. Following the sale, the director directly owned 49,001 shares of the company’s stock, valued at approximately $8,546,264.41. This trade represents a 0.51% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.81% of the company’s stock.

Analyst Ratings Changes A number of equities research analysts have recently weighed in on AVAV shares. Wall Street Zen upgraded AeroVironment from a “sell” rating to a “hold” rating in a research note on Sunday, July 5th. Weiss Ratings reiterated a “sell (d)” rating on shares of AeroVironment in a research note on Monday, June 8th. Piper Sandler dropped their target price on shares of AeroVironment from $248.00 to $235.00 and set an “overweight” rating on the stock in a research report on Thursday, July 9th. Clear Str upgraded shares of AeroVironment to a “strong-buy” rating in a research note on Wednesday, April 29th. Finally, Stifel Nicolaus decreased their price target on shares of AeroVironment from $315.00 to $220.00 and set a “buy” rating for the company in a report on Tuesday, June 30th. Two equities research analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $266.68.

Get Our Latest Stock Report on AVAV

More AeroVironment News Here are the key news stories impacting AeroVironment this week:

Positive Sentiment: AeroVironment won a $117.3 million U.S. Army contract for 82 P550 reconnaissance drones, boosting revenue visibility and validating its autonomous systems business. AV Awarded $117.3 Million U.S. Army Production Contract for P550™ Positive Sentiment: Investor interest in drone stocks remains strong, with sector rotation and short positioning potentially amplifying upside sentiment for AVAV. ONDS, AVAV, RCAT, RDW Rise Premarket: Investors Pour $10.7B Into Drone Stocks – S3 Sees ‘More Fireworks’ Ahead Positive Sentiment: Recent reports point to additional international wins, including Italy’s JUMP 20 military designation and German contract activity, supporting the bull case for AeroVironment’s NATO adoption. AeroVironment (AVAV) Wins Italian JUMP 20 Designation And German Drone Contracts Neutral Sentiment: Multiple law firms issued reminders about a July 27 lead-plaintiff deadline in securities class action cases tied to AVAV, keeping legal overhang in focus but not changing the underlying business fundamentals. AVAV Shareholder Alert: July 27, 2026 Lead Plaintiff Deadline in AeroVironment, Inc. Securities Class Action Negative Sentiment: The class-action lawsuits center on alleged misrepresentations about competitive risks in AeroVironment’s SCAR program and single-vendor contract vulnerability, which may continue to weigh on sentiment. JULY 27, 2026 DEADLINE ALERT: AeroVironment, Inc. (AVAV) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit AeroVironment Trading Up 0.3% Shares of NASDAQ:AVAV opened at $142.60 on Tuesday. The company has a quick ratio of 3.59, a current ratio of 4.30 and a debt-to-equity ratio of 0.17. AeroVironment, Inc. has a 52-week low of $135.20 and a 52-week high of $417.86. The stock has a market cap of $7.22 billion, a price-to-earnings ratio of -38.75, a PEG ratio of 4.84 and a beta of 1.39. The business has a 50-day moving average price of $167.69 and a 200-day moving average price of $215.88.

AeroVironment (NASDAQ:AVAV – Get Free Report) last issued its earnings results on Monday, June 29th. The aerospace company reported $1.84 EPS for the quarter, beating analysts’ consensus estimates of $1.47 by $0.37. The firm had revenue of $641.62 million for the quarter, compared to analyst estimates of $555.97 million. AeroVironment had a positive return on equity of 3.71% and a negative net margin of 9.00%.AeroVironment’s revenue for the quarter was up 133.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.61 earnings per share. AeroVironment has set its FY 2027 guidance at 3.020-3.340 EPS. Equities analysts predict that AeroVironment, Inc. will post 3.26 EPS for the current year.

AeroVironment Profile (Free Report)

AeroVironment, Inc (NASDAQ:AVAV) is a technology company specializing in unmanned aerial systems (UAS), tactical missiles and precision loitering munitions, electric vehicle charging and scalable energy systems. Headquartered in Monrovia, California, the company develops solutions for defense, public safety and commercial markets. Their offerings include small UAS for intelligence, surveillance and reconnaissance, as well as advanced weapons systems designed to meet the needs of modern military operations.

The company’s unmanned aerial systems portfolio features platforms such as the Raven, Puma and Switchblade series, which are deployed by the U.S.

See Also Five stocks we like better than AeroVironment The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding AVAV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AeroVironment, Inc. (NASDAQ:AVAV – Free Report).

Receive News & Ratings for AeroVironment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AeroVironment and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmova Asset Management Americas Inc. Increases Position in CareDx, Inc. $CDNA

NEXT HEADLINE »Amova Asset Management Americas Inc. Lowers Stake in Unity Software Inc. $U

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. trimmed its position in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 24.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 483,557 shares of the company’s stock after selling 156,738 shares during the period. Amova Asset Management Americas Inc. owned 0.36% of Guardant Health worth $44,608,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in GH. Vanguard Group Inc. increased its stake in shares of Guardant Health by 2.1% during the 4th quarter. Vanguard Group Inc. now owns 12,160,768 shares of the company’s stock worth $1,242,101,000 after purchasing an additional 251,939 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in Guardant Health by 33.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,636,078 shares of the company’s stock valued at $575,670,000 after buying an additional 1,414,441 shares during the period. Franklin Resources Inc. raised its stake in Guardant Health by 14.9% in the fourth quarter. Franklin Resources Inc. now owns 3,361,547 shares of the company’s stock valued at $343,348,000 after buying an additional 435,232 shares during the period. Geode Capital Management LLC lifted its position in shares of Guardant Health by 9.4% in the fourth quarter. Geode Capital Management LLC now owns 3,213,657 shares of the company’s stock valued at $328,297,000 after buying an additional 277,001 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its stake in shares of Guardant Health by 3.0% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,441,730 shares of the company’s stock worth $249,398,000 after acquiring an additional 72,162 shares during the period. 92.60% of the stock is owned by institutional investors.

Insider Activity In related news, Director Meghan V. Joyce sold 10,000 shares of the company’s stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $126.98, for a total value of $1,269,800.00. Following the transaction, the director directly owned 11,183 shares in the company, valued at approximately $1,420,017.34. This represents a 47.21% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Helmy Eltoukhy sold 100,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $126.30, for a total transaction of $12,630,000.00. Following the transaction, the chief executive officer directly owned 2,012,919 shares in the company, valued at approximately $254,231,669.70. This represents a 4.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 708,565 shares of company stock worth $90,556,597. Corporate insiders own 5.60% of the company’s stock.

Wall Street Analysts Forecast Growth A number of research analysts recently weighed in on the company. Guggenheim boosted their target price on Guardant Health from $160.00 to $190.00 and gave the stock a “buy” rating in a report on Thursday, July 16th. Wolfe Research assumed coverage on Guardant Health in a report on Tuesday, June 2nd. They set an “outperform” rating and a $150.00 price target for the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Guardant Health in a research report on Tuesday, April 21st. Piper Sandler set a $127.00 price objective on shares of Guardant Health in a report on Thursday, May 21st. Finally, Canaccord Genuity Group increased their price objective on shares of Guardant Health from $135.00 to $205.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. One analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $160.04.

Read Our Latest Stock Analysis on Guardant Health

Guardant Health Trading Down 5.0% NASDAQ:GH opened at $148.07 on Tuesday. The stock has a 50 day simple moving average of $135.24 and a 200 day simple moving average of $110.66. The stock has a market cap of $19.63 billion, a P/E ratio of -43.68 and a beta of 1.59. Guardant Health, Inc. has a 1-year low of $40.35 and a 1-year high of $174.08.

About Guardant Health (Free Report)

Guardant Health, Inc is a precision oncology company specializing in blood-based cancer diagnostics. Founded in 2012 and headquartered in Redwood City, California, the company develops non-invasive tests that use circulating tumor DNA (ctDNA) to profile genomic alterations in patients with solid tumors. Guardant Health’s mission is to advance cancer care by providing actionable data to clinicians, pharmaceutical partners and researchers worldwide.

The company’s flagship product, Guardant360, is a next-generation sequencing (NGS) assay designed to detect mutations, copy number variations and select fusions in more than 70 cancer-related genes.

See Also Five stocks we like better than Guardant Health The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding GH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardant Health, Inc. (NASDAQ:GH – Free Report).

Receive News & Ratings for Guardant Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardant Health and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmova Asset Management Americas Inc. Sells 1,207,787 Shares of DraftKings Inc. $DKNG

NEXT HEADLINE »Amova Asset Management Americas Inc. Cuts Stock Holdings in Rocket Lab Corporation $RKLB

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

ORIX Corporation (IX - Free Report) : This financial services company has seen the Zacks Consensus Estimate for its current year earnings increasing 55.7% over the last 60 days.

NVIDIA Corporation (NVDA - Free Report) : This data center AI infrastructure company has seen the Zacks Consensus Estimate for its current year earnings increasing 11% over the last 60 days.

Astronics Corporation (ATRO - Free Report) : This aerospace and defense company has seen the Zacks Consensus Estimate for its current year earnings increasing 18.6% over the last 60 days.

Fluence Energy, Inc. (FLNC - Free Report) : This energy storage software company has seen the Zacks Consensus Estimate for its current year earnings increasing 18.2% over the last 60 days.

AMC Entertainment Holdings, Inc. (AMC - Free Report) : This theater exhibition company and Trust Co has seen the Zacks Consensus Estimate for its current year earnings increasing 29% over the last 60 days.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. lifted its stake in shares of GitLab Inc. (NASDAQ:GTLB – Free Report) by 5.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 535,833 shares of the company’s stock after purchasing an additional 25,473 shares during the period. Amova Asset Management Americas Inc. owned 0.32% of GitLab worth $11,585,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the stock. Parallel Advisors LLC grew its holdings in shares of GitLab by 51.1% in the first quarter. Parallel Advisors LLC now owns 5,458 shares of the company’s stock valued at $118,000 after purchasing an additional 1,846 shares during the period. California Public Employees Retirement System raised its stake in GitLab by 3.2% during the first quarter. California Public Employees Retirement System now owns 200,216 shares of the company’s stock worth $4,333,000 after purchasing an additional 6,119 shares during the period. Watershed Asset Management L.L.C. raised its stake in GitLab by 18.5% during the first quarter. Watershed Asset Management L.L.C. now owns 64,000 shares of the company’s stock worth $1,385,000 after purchasing an additional 10,000 shares during the period. Assetmark Inc. boosted its holdings in GitLab by 7.8% in the 1st quarter. Assetmark Inc. now owns 39,646 shares of the company’s stock valued at $858,000 after purchasing an additional 2,862 shares during the last quarter. Finally, Fifth Third Bancorp boosted its holdings in GitLab by 220.6% in the 1st quarter. Fifth Third Bancorp now owns 1,603 shares of the company’s stock valued at $35,000 after purchasing an additional 1,103 shares during the last quarter. 95.04% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades GTLB has been the subject of several recent analyst reports. Truist Financial raised their target price on GitLab from $25.00 to $30.00 and gave the stock a “hold” rating in a research note on Thursday, July 9th. Guggenheim reiterated a “neutral” rating on shares of GitLab in a report on Wednesday, June 3rd. UBS Group increased their price target on GitLab from $32.00 to $35.00 and gave the stock a “neutral” rating in a report on Friday, July 10th. Bank of America reissued a “neutral” rating on shares of GitLab in a research report on Wednesday, June 3rd. Finally, William Blair reaffirmed an “underperform” rating on shares of GitLab in a research report on Monday, March 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, seventeen have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, GitLab currently has an average rating of “Hold” and a consensus price target of $36.58.

Check Out Our Latest Stock Report on GitLab

Insiders Place Their Bets In other GitLab news, Director Sytse Sijbrandij sold 116,200 shares of the company’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $28.44, for a total transaction of $3,304,728.00. Following the sale, the director owned 14,902,051 shares in the company, valued at $423,814,330.44. This represents a 0.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.64% of the stock is currently owned by company insiders.

GitLab Price Performance NASDAQ GTLB opened at $34.07 on Tuesday. The company has a market cap of $5.75 billion, a P/E ratio of -212.94 and a beta of 0.96. The stock has a 50-day moving average of $29.11 and a two-hundred day moving average of $28.01. GitLab Inc. has a 1-year low of $18.73 and a 1-year high of $52.38.

GitLab (NASDAQ:GTLB – Get Free Report) last announced its earnings results on Tuesday, June 2nd. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.03. GitLab had a negative net margin of 2.49% and a positive return on equity of 0.31%. The firm had revenue of $264.16 million for the quarter, compared to the consensus estimate of $254.23 million. During the same period in the prior year, the firm earned $0.17 EPS. The firm’s revenue for the quarter was up 23.2% on a year-over-year basis. GitLab has set its Q2 2027 guidance at 0.170-0.180 EPS. On average, analysts anticipate that GitLab Inc. will post -0.18 EPS for the current fiscal year.

GitLab Company Profile (Free Report)

GitLab Inc (NASDAQ: GTLB) is a leading provider of a unified DevOps platform designed to streamline the software development lifecycle. Founded in 2011 by Dmitriy Zaporozhets and Sid Sijbrandij, the company initially gained recognition for its open-source Git repository manager. Over time, GitLab expanded its offerings to encompass planning, source code management, continuous integration/continuous deployment (CI/CD), security testing, and monitoring in a single application. This integrated approach enables development teams to collaborate efficiently, reduce toolchain complexity, and accelerate release cycles.

The GitLab platform is offered through both cloud-hosted and self-managed deployment models, catering to organizations of all sizes.

Featured Stories Five stocks we like better than GitLab The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for GitLab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GitLab and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmova Asset Management Americas Inc. Has $13.61 Million Stock Holdings in Pinterest, Inc. $PINS

HomeEarnings AnalysisConsumer Staples Analysis

SummaryGrocery Outlet remains a tactical 'Hold' as the turnaround lacks clear catalysts and Q1 FY 2026 results were disappointing.GO's same-store sales fell 1% with traffic up 2.1% but average ticket down 3.1%, highlighting persistent operational challenges.Despite trading at ~11.8x EBITDA, GO is not cheap relative to peers and offers limited near-term upside with a revised price target of $8.70.Optionality exists if operations stabilize by FY 2028, but current fundamentals do not justify a buy; risk reduction is prudent for large holders. njpPhoto/iStock Unreleased via Getty Images

Shopping. Some people love it, others hate it.

I'm definitely in the second group.

Still, if I go alone and forget something important for my wife, I'll definitely hear about it.

It sounds like

949 Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. decreased its holdings in shares of SoFi Technologies, Inc. (NASDAQ:SOFI – Free Report) by 4.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,136,479 shares of the company’s stock after selling 161,725 shares during the quarter. Amova Asset Management Americas Inc. owned approximately 0.25% of SoFi Technologies worth $49,839,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the stock. SG Americas Securities LLC lifted its stake in shares of SoFi Technologies by 161.6% in the 4th quarter. SG Americas Securities LLC now owns 902,392 shares of the company’s stock valued at $23,625,000 after purchasing an additional 557,390 shares in the last quarter. Vanguard Group Inc. increased its position in SoFi Technologies by 3.6% during the 4th quarter. Vanguard Group Inc. now owns 111,003,107 shares of the company’s stock worth $2,906,061,000 after purchasing an additional 3,900,895 shares in the last quarter. North Dakota State Investment Board purchased a new position in SoFi Technologies in the fourth quarter valued at approximately $1,044,000. Brighton Jones LLC lifted its position in SoFi Technologies by 2.0% during the fourth quarter. Brighton Jones LLC now owns 719,288 shares of the company’s stock valued at $11,077,000 after buying an additional 14,281 shares in the last quarter. Finally, Friedenthal Financial acquired a new position in SoFi Technologies during the fourth quarter valued at approximately $926,000. 38.43% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes Several equities research analysts have recently issued reports on SOFI shares. UBS Group dropped their price objective on shares of SoFi Technologies from $24.50 to $21.00 and set a “neutral” rating for the company in a research report on Thursday, April 30th. Stephens decreased their price target on shares of SoFi Technologies from $26.00 to $25.00 and set an “overweight” rating for the company in a research report on Thursday, April 30th. Argus began coverage on SoFi Technologies in a report on Wednesday, April 15th. They issued a “hold” rating for the company. Citigroup cut their price objective on SoFi Technologies from $37.00 to $30.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Finally, Barclays reduced their price objective on SoFi Technologies from $28.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Monday, April 6th. Seven analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $22.78.

View Our Latest Analysis on SoFi Technologies

Insiders Place Their Bets In other SoFi Technologies news, CTO Jeremy Rishel sold 102,123 shares of the company’s stock in a transaction that occurred on Wednesday, June 17th. The stock was sold at an average price of $17.78, for a total value of $1,815,746.94. Following the transaction, the chief technology officer directly owned 895,089 shares of the company’s stock, valued at $15,914,682.42. This represents a 10.24% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Kelli Keough sold 10,954 shares of the stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $17.35, for a total value of $190,051.90. Following the transaction, the executive vice president owned 378,682 shares of the company’s stock, valued at approximately $6,570,132.70. This trade represents a 2.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 124,302 shares of company stock worth $2,182,523 in the last three months. 2.50% of the stock is owned by insiders.

SoFi Technologies Price Performance SOFI opened at $17.01 on Tuesday. SoFi Technologies, Inc. has a twelve month low of $14.92 and a twelve month high of $32.73. The firm has a market cap of $21.82 billion, a price-to-earnings ratio of 38.66 and a beta of 2.14. The company has a current ratio of 0.75, a quick ratio of 0.13 and a debt-to-equity ratio of 0.17. The company has a fifty day simple moving average of $17.11 and a 200 day simple moving average of $19.04.

SoFi Technologies (NASDAQ:SOFI – Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.12 EPS for the quarter, hitting analysts’ consensus estimates of $0.12. SoFi Technologies had a net margin of 14.65% and a return on equity of 6.25%. The firm had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the previous year, the business posted $0.06 EPS. The firm’s revenue was up 42.6% compared to the same quarter last year. SoFi Technologies has set its FY 2026 guidance at 0.600- EPS. Equities research analysts expect that SoFi Technologies, Inc. will post 0.59 EPS for the current fiscal year.

SoFi Technologies Profile (Free Report)

SoFi Technologies, Inc (NASDAQ: SOFI) is a diversified financial services company that provides consumer-focused lending, banking, investing and financial technology products. The company’s core offerings include student loan refinancing and private student loans, personal loans, mortgage lending, and credit card products. In addition to credit and lending, SoFi operates consumer-facing deposit and cash management accounts, an investing and trading platform, and an insurance marketplace through partner relationships, all designed to serve individuals seeking an integrated digital financial experience.

SoFi has grown beyond direct-to-consumer lending by building technology and infrastructure capabilities.

Featured Stories Five stocks we like better than SoFi Technologies The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for SoFi Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SoFi Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmova Asset Management Americas Inc. Grows Holdings in WeRide Inc. $WRD

NEXT HEADLINE »Royal Bank Of Canada Issues Positive Forecast for Fifth Third Bancorp (NASDAQ:FITB) Stock Price

Posted by Defense World Staff on Jul 21st, 2026

Allspring Global Investments Holdings LLC increased its position in shares of Kontoor Brands, Inc. (NYSE:KTB – Free Report) by 54.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 298,072 shares of the company’s stock after purchasing an additional 104,466 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.54% of Kontoor Brands worth $21,133,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in KTB. Norges Bank bought a new stake in shares of Kontoor Brands in the fourth quarter valued at about $36,185,000. Boston Partners bought a new position in Kontoor Brands during the third quarter worth about $44,733,000. JPMorgan Chase & Co. raised its stake in Kontoor Brands by 15.8% in the 4th quarter. JPMorgan Chase & Co. now owns 3,019,204 shares of the company’s stock worth $184,443,000 after purchasing an additional 413,005 shares in the last quarter. Amundi acquired a new stake in Kontoor Brands in the 3rd quarter worth about $24,653,000. Finally, Balyasny Asset Management L.P. boosted its holdings in Kontoor Brands by 134.3% in the 2nd quarter. Balyasny Asset Management L.P. now owns 468,630 shares of the company’s stock valued at $30,916,000 after purchasing an additional 268,604 shares during the period. 93.06% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades A number of brokerages have issued reports on KTB. BTIG Research restated a “buy” rating and set a $100.00 target price on shares of Kontoor Brands in a research report on Friday, May 1st. Weiss Ratings cut Kontoor Brands from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, June 15th. Wall Street Zen downgraded Kontoor Brands from a “strong-buy” rating to a “hold” rating in a research report on Saturday, May 9th. Zacks Research raised Kontoor Brands from a “strong sell” rating to a “hold” rating in a research report on Thursday, July 9th. Finally, JPMorgan Chase & Co. began coverage on Kontoor Brands in a research note on Monday, June 8th. They set an “overweight” rating and a $90.00 price objective on the stock. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Kontoor Brands presently has an average rating of “Moderate Buy” and a consensus price target of $91.20.

Check Out Our Latest Research Report on KTB

Kontoor Brands Price Performance Shares of NYSE:KTB opened at $83.30 on Tuesday. The firm has a 50 day moving average of $76.55 and a 200-day moving average of $70.68. Kontoor Brands, Inc. has a 12 month low of $53.55 and a 12 month high of $88.96. The company has a current ratio of 1.87, a quick ratio of 1.10 and a debt-to-equity ratio of 1.83. The stock has a market capitalization of $4.60 billion, a PE ratio of 16.86 and a beta of 0.87.

Kontoor Brands (NYSE:KTB – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported $1.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.17 by ($0.11). Kontoor Brands had a return on equity of 60.17% and a net margin of 8.30%.The firm had revenue of $613.32 million for the quarter, compared to analyst estimates of $784.76 million. During the same quarter in the prior year, the business posted $1.20 EPS. The business’s revenue was up 45.0% on a year-over-year basis. Kontoor Brands has set its FY 2026 guidance at 6.600-6.700 EPS. On average, equities research analysts predict that Kontoor Brands, Inc. will post 5.2 EPS for the current fiscal year.

Kontoor Brands Dividend Announcement The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 8th were issued a dividend of $0.53 per share. The ex-dividend date of this dividend was Monday, June 8th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. Kontoor Brands’s payout ratio is 42.91%.

Insider Activity at Kontoor Brands In related news, EVP Jennifer H. Broyles sold 4,000 shares of the company’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $81.02, for a total transaction of $324,080.00. Following the completion of the sale, the executive vice president directly owned 40,261 shares in the company, valued at $3,261,946.22. This represents a 9.04% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.80% of the company’s stock.

Kontoor Brands Company Profile (Free Report)

Kontoor Brands, Inc is a global apparel company best known for its Wrangler and Lee denim and lifestyle brands. Established as an independent, publicly traded company in May 2019 following a spin-off from VF Corporation, Kontoor leverages a legacy that dates back to 1889 with the founding of Lee and to 1947 with the introduction of the Wrangler brand. The company focuses on designing, manufacturing and distributing premium, casual and workwear apparel, including jeans, pants, shorts, shirts, jackets and complementary accessories.

Kontoor Brands operates a diversified sales model that combines wholesale partnerships with leading retailers, distribution through e-commerce channels and select direct-to-consumer formats.

See Also Five stocks we like better than Kontoor Brands The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Kontoor Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kontoor Brands and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAllspring Global Investments Holdings LLC Increases Holdings in CONMED Corporation $CNMD

NEXT HEADLINE »Pathward Financial, Inc. $CASH Stock Holdings Lifted by Allspring Global Investments Holdings LLC

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. decreased its stake in Archer Aviation Inc. (NYSE:ACHR – Free Report) by 3.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,651,742 shares of the company’s stock after selling 262,449 shares during the quarter. Amova Asset Management Americas Inc. owned approximately 1.03% of Archer Aviation worth $39,560,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the stock. Norges Bank acquired a new position in Archer Aviation in the fourth quarter worth $58,494,000. Man Group plc raised its stake in shares of Archer Aviation by 13,793.3% in the second quarter. Man Group plc now owns 4,212,722 shares of the company’s stock worth $45,708,000 after acquiring an additional 4,182,400 shares during the last quarter. BNP Paribas Financial Markets lifted its position in shares of Archer Aviation by 423.3% during the fourth quarter. BNP Paribas Financial Markets now owns 5,126,217 shares of the company’s stock worth $38,549,000 after purchasing an additional 4,146,574 shares in the last quarter. ARK Investment Management LLC lifted its position in shares of Archer Aviation by 12.4% during the fourth quarter. ARK Investment Management LLC now owns 35,170,701 shares of the company’s stock worth $264,484,000 after purchasing an additional 3,869,252 shares in the last quarter. Finally, State Street Corp grew its stake in shares of Archer Aviation by 11.2% during the fourth quarter. State Street Corp now owns 32,773,136 shares of the company’s stock valued at $246,454,000 after purchasing an additional 3,293,130 shares during the last quarter. 59.34% of the stock is currently owned by institutional investors.

Archer Aviation Stock Performance Shares of Archer Aviation stock opened at $5.33 on Tuesday. The firm has a fifty day moving average of $5.55 and a two-hundred day moving average of $6.34. The company has a debt-to-equity ratio of 0.06, a quick ratio of 18.06 and a current ratio of 18.06. The stock has a market capitalization of $4.04 billion, a price-to-earnings ratio of -4.84 and a beta of 3.19. Archer Aviation Inc. has a 52 week low of $4.30 and a 52 week high of $14.62.

Archer Aviation (NYSE:ACHR – Get Free Report) last issued its earnings results on Monday, May 11th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.03). The business had revenue of $1.60 million during the quarter, compared to analysts’ expectations of $1.66 million. During the same quarter in the prior year, the business posted ($0.17) EPS. As a group, equities research analysts predict that Archer Aviation Inc. will post -1.47 EPS for the current year.

Analysts Set New Price Targets A number of research analysts have commented on the company. Canaccord Genuity Group decreased their price objective on Archer Aviation from $13.00 to $12.00 and set a “buy” rating on the stock in a research report on Tuesday, May 12th. Weiss Ratings restated a “sell (d-)” rating on shares of Archer Aviation in a research report on Friday. Four equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Archer Aviation currently has a consensus rating of “Hold” and a consensus price target of $11.83.

Read Our Latest Report on ACHR

More Archer Aviation News Here are the key news stories impacting Archer Aviation this week:

Positive Sentiment: Archer and Anduril introduced “Thunder,” an autonomous VTOL platform designed for both defense and commercial use, giving Archer a new growth avenue beyond urban air mobility. Anduril and Archer Unveil Jointly-Developed Autonomous VTOL Platform For Commercial and Defense Applications Positive Sentiment: The market is reacting favorably to Archer’s push into defense, with the new platform seen as a potential way to speed commercialization and diversify revenue sources. Archer, Anduril unveil autonomous aircraft platform for defense, commercial markets Positive Sentiment: Investor sentiment was also supported by management reiterating Archer’s goal to achieve certification by 2028, which suggests continued progress toward commercialization. Archer CEO reaffirms ‘ambitious’ 2028 flight goal as company unveils military craft with Anduril Insider Activity In other Archer Aviation news, CAO Harsh Rungta sold 12,414 shares of the company’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $5.95, for a total value of $73,863.30. Following the completion of the sale, the chief accounting officer owned 87,210 shares of the company’s stock, valued at approximately $518,899.50. This represents a 12.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Eric Lentell sold 48,169 shares of the company’s stock in a transaction on Monday, May 18th. The shares were sold at an average price of $5.95, for a total transaction of $286,605.55. Following the completion of the sale, the insider owned 141,084 shares of the company’s stock, valued at approximately $839,449.80. This represents a 25.45% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 250,743 shares of company stock worth $1,497,672 in the last ninety days. Company insiders own 5.55% of the company’s stock.

About Archer Aviation (Free Report)

Archer Aviation, Inc (NYSE: ACHR) is a California-based aerospace company developing electric vertical takeoff and landing (eVTOL) aircraft designed to serve as sustainable urban air mobility solutions. Founded in 2018 by Adam Goldstein and Brett Adcock, Archer focuses on the design, development and certification of zero-emissions air taxis aimed at reducing traffic congestion in densely populated metropolitan areas. The company’s flagship prototypes, “Maker” and “Midnight,” have been engineered to deliver quiet, efficient short-haul flights with ranges of up to 100 miles per charge.

Headquartered in Palo Alto, California, Archer operates a manufacturing facility in nearby Santa Cruz County and maintains research partnerships with automotive and energy companies, including a collaboration with Stellantis to integrate advanced battery systems.

Further Reading Five stocks we like better than Archer Aviation The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Archer Aviation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Archer Aviation and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECorteva, Inc. $CTVA Shares Sold by Amova Asset Management Americas Inc.

NEXT HEADLINE »American Airlines Group (AAL) to Post Earnings on Thursday

Allspring Global Investments Holdings LLC lessened its holdings in shares of Werner Enterprises, Inc. (NASDAQ: WERN) by 57.4% in the first quarter, according to its most recent filing with the SEC. The firm owned 685,671 shares of the transportation company's stock after selling 925,642 shares during the period. Allspring Global Investments Holdings LLC

Posted by Defense World Staff on Jul 21st, 2026

Allspring Global Investments Holdings LLC trimmed its position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 63.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 266,615 shares of the company’s stock after selling 462,895 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.32% of HealthEquity worth $22,230,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Wasatch Advisors LP raised its stake in shares of HealthEquity by 9.3% during the 1st quarter. Wasatch Advisors LP now owns 7,202,934 shares of the company’s stock worth $601,949,000 after buying an additional 613,288 shares in the last quarter. Geode Capital Management LLC lifted its holdings in HealthEquity by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 2,201,232 shares of the company’s stock valued at $201,685,000 after acquiring an additional 5,671 shares during the period. Westfield Capital Management Co. LP boosted its position in shares of HealthEquity by 13.7% during the 4th quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock worth $178,864,000 after purchasing an additional 235,794 shares in the last quarter. William Blair Investment Management LLC purchased a new stake in shares of HealthEquity during the 4th quarter worth $169,956,000. Finally, AQR Capital Management LLC grew its stake in shares of HealthEquity by 59.3% during the 3rd quarter. AQR Capital Management LLC now owns 1,764,268 shares of the company’s stock worth $167,200,000 after purchasing an additional 656,820 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In A number of equities analysts have recently issued reports on the stock. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Wells Fargo & Company set a $111.00 price objective on shares of HealthEquity in a report on Monday, June 1st. Barrington Research restated an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a research report on Friday, May 22nd. Wall Street Zen cut shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, July 4th. Finally, Weiss Ratings upgraded shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. Eleven research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $110.57.

Get Our Latest Research Report on HQY

HealthEquity Trading Up 1.2% NASDAQ:HQY opened at $98.88 on Tuesday. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $105.96. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The stock has a fifty day simple moving average of $89.10 and a 200-day simple moving average of $84.77. The company has a market capitalization of $8.27 billion, a PE ratio of 37.03, a price-to-earnings-growth ratio of 1.64 and a beta of 0.21.

HealthEquity (NASDAQ:HQY – Get Free Report) last issued its quarterly earnings data on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The firm had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. HealthEquity’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities research analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity In related news, EVP Michael Henry Fiore sold 3,142 shares of HealthEquity stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the transaction, the executive vice president directly owned 59,113 shares in the company, valued at $5,615,735. The trade was a 5.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director directly owned 19,733 shares of the company’s stock, valued at approximately $1,775,970. This trade represents a 11.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,905 shares of company stock valued at $1,651,280 in the last ninety days. Corporate insiders own 1.60% of the company’s stock.

About HealthEquity (Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Featured Articles Five stocks we like better than HealthEquity The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAllspring Global Investments Holdings LLC Has $23.99 Million Stake in Chewy $CHWY

NEXT HEADLINE »Allspring Global Investments Holdings LLC Sells 185,718 Shares of Cigna Group $CI

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. cut its position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 9.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,037,987 shares of the biotechnology company’s stock after selling 770,593 shares during the period. Amova Asset Management Americas Inc. owned 2.27% of Pacific Biosciences of California worth $9,220,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of PACB. UBS Group AG grew its stake in shares of Pacific Biosciences of California by 111.8% during the fourth quarter. UBS Group AG now owns 3,171,546 shares of the biotechnology company’s stock worth $5,931,000 after buying an additional 1,674,320 shares during the last quarter. Casdin Capital LLC increased its holdings in shares of Pacific Biosciences of California by 483.6% during the fourth quarter. Casdin Capital LLC now owns 4,223,767 shares of the biotechnology company’s stock worth $7,898,000 after buying an additional 3,500,000 shares in the last quarter. Main Street Research LLC bought a new position in shares of Pacific Biosciences of California in the 1st quarter valued at $201,000. Hartline Investment Corp lifted its stake in shares of Pacific Biosciences of California by 122.6% in the 1st quarter. Hartline Investment Corp now owns 69,000 shares of the biotechnology company’s stock valued at $91,000 after acquiring an additional 38,000 shares during the last quarter. Finally, AdvisorNet Financial Inc boosted its holdings in shares of Pacific Biosciences of California by 6.2% during the 1st quarter. AdvisorNet Financial Inc now owns 142,057 shares of the biotechnology company’s stock valued at $188,000 after acquiring an additional 8,290 shares in the last quarter.

Analyst Upgrades and Downgrades Several research analysts have recently issued reports on PACB shares. Barclays upped their price objective on Pacific Biosciences of California from $1.00 to $1.50 and gave the company an “underweight” rating in a research note on Monday, May 11th. Zacks Research lowered shares of Pacific Biosciences of California from a “strong-buy” rating to a “hold” rating in a report on Monday, April 20th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Pacific Biosciences of California in a research report on Tuesday, April 21st. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $1.83.

View Our Latest Stock Analysis on PACB

Pacific Biosciences of California Price Performance NASDAQ PACB opened at $1.36 on Tuesday. The stock has a market capitalization of $422.42 million, a price-to-earnings ratio of -3.16 and a beta of 2.29. Pacific Biosciences of California, Inc. has a one year low of $1.09 and a one year high of $2.73. The business’s fifty day moving average is $1.43 and its 200-day moving average is $1.62.

Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The biotechnology company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.17) by $0.05. The company had revenue of $37.18 million during the quarter, compared to analyst estimates of $39.94 million. Pacific Biosciences of California had a negative return on equity of 571.06% and a negative net margin of 80.35%. Research analysts expect that Pacific Biosciences of California, Inc. will post -0.5 EPS for the current fiscal year.

About Pacific Biosciences of California (Free Report)

Pacific Biosciences of California, Inc develops, manufactures and sells high-performance DNA sequencing systems for genetic and genomic analysis. The company’s proprietary single-molecule, real-time (SMRT) sequencing technology is designed to enable long-read sequencing, offering high accuracy for applications such as de novo genome assembly, transcriptome characterization and structural variation analysis. Pacific Biosciences markets a suite of instruments, including the Sequel and Sequel IIe systems, alongside reagents, consumables and data analysis software to support a range of life science research.

Founded in 2004 and headquartered in Menlo Park, California, Pacific Biosciences has expanded its global reach by serving academic institutions, biotechnology and pharmaceutical companies, and government research centers across North America, Europe and Asia.

See Also Five stocks we like better than Pacific Biosciences of California The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding PACB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report).

Receive News & Ratings for Pacific Biosciences of California Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pacific Biosciences of California and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEPrime Medicine, Inc. $PRME Shares Sold by Amova Asset Management Americas Inc.

NEXT HEADLINE »Amova Asset Management Americas Inc. Has $13.61 Million Stock Holdings in Pinterest, Inc. $PINS

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. cut its holdings in shares of Nu Holdings Ltd. (NYSE:NU – Free Report) by 1.2% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,395,488 shares of the company’s stock after selling 54,907 shares during the quarter. Amova Asset Management Americas Inc. owned 0.09% of NU worth $63,163,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in NU. Kapitalo Investimentos Ltda bought a new stake in shares of NU in the 1st quarter valued at about $10,002,000. AlTi Global Inc. increased its stake in NU by 2.0% in the 1st quarter. AlTi Global Inc. now owns 65,411 shares of the company’s stock worth $940,000 after purchasing an additional 1,275 shares during the period. Earned Wealth Advisors LLC lifted its position in NU by 15.7% in the first quarter. Earned Wealth Advisors LLC now owns 22,292 shares of the company’s stock valued at $320,000 after purchasing an additional 3,023 shares during the last quarter. Investment Management Associates Inc. ADV lifted its position in NU by 15.6% in the first quarter. Investment Management Associates Inc. ADV now owns 1,073,617 shares of the company’s stock valued at $15,428,000 after purchasing an additional 144,894 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of NU by 990.3% during the first quarter. Dimensional Fund Advisors LP now owns 298,789 shares of the company’s stock valued at $4,294,000 after purchasing an additional 271,385 shares during the period. 84.02% of the stock is currently owned by institutional investors.

Insider Activity In other news, Director Anita M. Sands sold 21,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $12.24, for a total value of $257,040.00. Following the transaction, the director owned 162,150 shares in the company, valued at approximately $1,984,716. This represents a 11.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link.

NU Stock Performance NYSE:NU opened at $14.03 on Tuesday. The stock has a market cap of $68.13 billion, a P/E ratio of 21.59, a price-to-earnings-growth ratio of 0.54 and a beta of 0.95. The firm’s fifty day simple moving average is $12.90 and its 200 day simple moving average is $14.75. Nu Holdings Ltd. has a twelve month low of $11.20 and a twelve month high of $18.98. The company has a quick ratio of 0.58, a current ratio of 0.58 and a debt-to-equity ratio of 0.36.

NU (NYSE:NU – Get Free Report) last announced its earnings results on Friday, May 15th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.01). NU had a return on equity of 30.91% and a net margin of 18.20%.The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.06 billion. As a group, research analysts predict that Nu Holdings Ltd. will post 0.83 EPS for the current year.

NU announced that its board has approved a share buyback program on Thursday, June 4th that allows the company to repurchase $0.00 in shares. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Shares repurchase programs are generally an indication that the company’s management believes its shares are undervalued.

Wall Street Analysts Forecast Growth NU has been the topic of several recent analyst reports. Susquehanna cut shares of NU from a “positive” rating to a “neutral” rating and cut their target price for the stock from $18.00 to $13.00 in a report on Wednesday, June 3rd. Needham & Company LLC assumed coverage on shares of NU in a report on Friday, June 26th. They set a “buy” rating and a $17.00 price target for the company. Bank of America reissued an “underperform” rating on shares of NU in a research report on Tuesday, June 2nd. Scotiabank lowered shares of NU to a “sector perform” rating and set a $13.00 price target on the stock. in a report on Wednesday, June 3rd. Finally, Zacks Research cut shares of NU from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 24th. Ten equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $17.24.

Read Our Latest Analysis on NU

NU Company Profile (Free Report)

Nu Holdings Ltd (NYSE: NU), commonly known by its consumer brand Nubank, is a Latin American financial technology company that provides digital banking and financial services through a mobile-first platform. The company’s core offerings include no-fee digital checking accounts, credit cards, personal loans, payments and transfers, and a range of savings and investment products. Nubank emphasizes a streamlined customer experience delivered via its smartphone app, combined with data-driven underwriting and automated customer service tools.

Founded in 2013 by David Vélez, Cristina Junqueira and Edward Wible, Nu grew rapidly by targeting underbanked and digitally savvy consumers in Latin America with low-fee, transparent products.

Featured Stories Five stocks we like better than NU The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for NU Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NU and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBristol Myers Squibb Company $BMY Shares Sold by AlTi Global Inc.

NEXT HEADLINE »AlTi Global Inc. Makes New $2.37 Million Investment in Investar Holding Corporation $ISTR

Allspring Global Investments Holdings LLC increased its stake in Levi Strauss & Co. (NYSE:LEVI – Free Report) by 12.6% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,325,256 shares of the blue-jean maker’s stock after buying an additional 148,067 shares during the period. Allspring Global Investments Holdings LLC owned 0.34% of Levi Strauss & Co. worth $25,180,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in LEVI. Vanguard Group Inc. boosted its stake in Levi Strauss & Co. by 3.8% in the 4th quarter. Vanguard Group Inc. now owns 9,320,747 shares of the blue-jean maker’s stock worth $193,312,000 after purchasing an additional 342,009 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Levi Strauss & Co. by 462.4% during the first quarter. Bank of New York Mellon Corp now owns 4,839,861 shares of the blue-jean maker’s stock valued at $89,489,000 after buying an additional 3,979,223 shares during the last quarter. Goldman Sachs Group Inc. increased its position in shares of Levi Strauss & Co. by 44.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,243,680 shares of the blue-jean maker’s stock valued at $88,014,000 after acquiring an additional 1,296,474 shares in the last quarter. Balyasny Asset Management L.P. increased its position in shares of Levi Strauss & Co. by 9.3% during the third quarter. Balyasny Asset Management L.P. now owns 3,457,702 shares of the blue-jean maker’s stock valued at $80,564,000 after acquiring an additional 294,053 shares in the last quarter. Finally, GW&K Investment Management LLC raised its holdings in Levi Strauss & Co. by 31.5% in the 4th quarter. GW&K Investment Management LLC now owns 2,219,599 shares of the blue-jean maker’s stock worth $46,034,000 after acquiring an additional 531,963 shares during the last quarter. Institutional investors own 69.14% of the company’s stock.

Insider Buying and Selling at Levi Strauss & Co. In other news, major shareholder Margaret E. Haas sold 47,721 shares of the company’s stock in a transaction dated Thursday, June 11th. The shares were sold at an average price of $24.01, for a total transaction of $1,145,781.21. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder E. Haas Jr. Family Fund Peter sold 145,662 shares of the stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $24.01, for a total transaction of $3,497,344.62. Following the completion of the transaction, the insider owned 145,662 shares in the company, valued at $3,497,344.62. This trade represents a 50.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,236,803 shares of company stock worth $28,742,192 in the last three months. 1.08% of the stock is currently owned by company insiders.

Levi Strauss & Co. Price Performance Shares of LEVI opened at $23.98 on Tuesday. The firm has a market cap of $9.23 billion, a PE ratio of 14.81, a P/E/G ratio of 1.61 and a beta of 1.33. The company has a current ratio of 1.60, a quick ratio of 0.98 and a debt-to-equity ratio of 0.46. The firm has a fifty day simple moving average of $23.33 and a two-hundred day simple moving average of $21.78. Levi Strauss & Co. has a 1-year low of $17.72 and a 1-year high of $25.58.

Levi Strauss & Co. (NYSE:LEVI – Get Free Report) last released its quarterly earnings results on Wednesday, July 8th. The blue-jean maker reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.04. The firm had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.52 billion. Levi Strauss & Co. had a return on equity of 25.79% and a net margin of 9.66%.The company’s revenue was up 8.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.22 EPS. Levi Strauss & Co. has set its FY 2026 guidance at 1.460-1.520 EPS. On average, equities analysts anticipate that Levi Strauss & Co. will post 1.54 EPS for the current year.

Levi Strauss & Co. Increases Dividend The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 5th. Shareholders of record on Wednesday, July 22nd will be paid a dividend of $0.16 per share. The ex-dividend date is Wednesday, July 22nd. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.7%. This is an increase from Levi Strauss & Co.’s previous quarterly dividend of $0.14. Levi Strauss & Co.’s dividend payout ratio is presently 34.57%.

Wall Street Analysts Forecast Growth LEVI has been the topic of several analyst reports. Raymond James Financial upped their price objective on Levi Strauss & Co. from $25.00 to $27.00 and gave the company an “outperform” rating in a research report on Thursday, July 2nd. UBS Group reissued a “buy” rating and issued a $34.00 target price on shares of Levi Strauss & Co. in a report on Thursday, July 9th. Barclays boosted their price target on Levi Strauss & Co. from $26.00 to $27.00 and gave the stock an “overweight” rating in a research note on Friday, July 10th. Wall Street Zen raised Levi Strauss & Co. from a “hold” rating to a “strong-buy” rating in a report on Saturday, April 11th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $28.00 price objective on shares of Levi Strauss & Co. in a research report on Thursday, July 9th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Levi Strauss & Co. currently has a consensus rating of “Moderate Buy” and an average target price of $27.46.

View Our Latest Stock Analysis on Levi Strauss & Co.

About Levi Strauss & Co. (Free Report)

Levi Strauss & Co is a global apparel company best known for its denim jeans and casual wear. Founded in 1853 in San Francisco by Bavarian immigrant Levi Strauss, the company pioneered the modern blue jean with the introduction of rivet-reinforced work pants. Over its more than 160-year history, Levi Strauss has evolved into a lifestyle brand, offering a broad portfolio that includes denim for men, women and children, as well as tops, outerwear, footwear and accessories.

The company’s flagship label, Levi’s®, is recognized worldwide for its iconic styles such as the 501® Original Fit Jeans, while additional brands, including Dockers®, Target core metric, and Denizen® by Levi’s, cater to diverse price points and consumer segments.

Featured Articles Five stocks we like better than Levi Strauss & Co. The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding LEVI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Levi Strauss & Co. (NYSE:LEVI – Free Report).

Receive News & Ratings for Levi Strauss & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Levi Strauss & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Posted by Defense World Staff on Jul 21st, 2026

Andar Capital Management HK Ltd purchased a new stake in Applied Optoelectronics, Inc. (NASDAQ:AAOI – Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 134,000 shares of the semiconductor company’s stock, valued at approximately $11,335,000. Applied Optoelectronics makes up 9.7% of Andar Capital Management HK Ltd’s holdings, making the stock its 4th largest holding. Andar Capital Management HK Ltd owned 0.17% of Applied Optoelectronics as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Hollencrest Capital Management bought a new stake in Applied Optoelectronics during the 1st quarter worth approximately $208,000. KBC Group NV bought a new position in Applied Optoelectronics in the 1st quarter valued at $164,000. Swiss National Bank raised its position in Applied Optoelectronics by 9.8% in the 1st quarter. Swiss National Bank now owns 128,300 shares of the semiconductor company’s stock valued at $10,853,000 after purchasing an additional 11,500 shares during the last quarter. Jennison Associates LLC acquired a new position in Applied Optoelectronics in the first quarter worth $435,000. Finally, Independent Financial Group LLC bought a new stake in shares of Applied Optoelectronics during the first quarter worth $646,000. 61.70% of the stock is owned by institutional investors.

Applied Optoelectronics Price Performance Applied Optoelectronics stock opened at $103.02 on Tuesday. The business’s 50-day simple moving average is $157.75 and its 200 day simple moving average is $111.55. The company has a quick ratio of 3.03, a current ratio of 3.83 and a debt-to-equity ratio of 0.18. The stock has a market cap of $8.27 billion, a price-to-earnings ratio of -156.09 and a beta of 3.69. Applied Optoelectronics, Inc. has a 12-month low of $18.50 and a 12-month high of $233.67.

Applied Optoelectronics (NASDAQ:AAOI – Get Free Report) last issued its earnings results on Thursday, May 7th. The semiconductor company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.02). Applied Optoelectronics had a negative net margin of 8.55% and a negative return on equity of 4.64%. The business had revenue of $151.14 million during the quarter, compared to the consensus estimate of $156.98 million. During the same period last year, the business posted ($0.02) EPS. The firm’s revenue for the quarter was up 51.3% compared to the same quarter last year. Applied Optoelectronics has set its Q2 2026 guidance at -0.030-0.030 EPS. As a group, research analysts anticipate that Applied Optoelectronics, Inc. will post 0.6 earnings per share for the current year.

Analyst Ratings Changes A number of brokerages have recently weighed in on AAOI. Rosenblatt Securities restated a “buy” rating and issued a $220.00 target price on shares of Applied Optoelectronics in a research note on Monday, June 22nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Applied Optoelectronics in a research report on Tuesday, July 7th. Raymond James Financial restated an “outperform” rating on shares of Applied Optoelectronics in a research report on Wednesday, June 10th. Finally, Wall Street Zen downgraded shares of Applied Optoelectronics from a “hold” rating to a “sell” rating in a research note on Monday, April 13th. Three research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Applied Optoelectronics presently has a consensus rating of “Hold” and an average target price of $113.80.

Check Out Our Latest Stock Analysis on Applied Optoelectronics

Insiders Place Their Bets In other Applied Optoelectronics news, insider Hung-Lun (Fred) Chang sold 40,329 shares of the stock in a transaction dated Wednesday, June 17th. The stock was sold at an average price of $170.60, for a total value of $6,880,127.40. Following the transaction, the insider owned 286,124 shares of the company’s stock, valued at approximately $48,812,754.40. This represents a 12.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider David C. Kuo sold 29,227 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $166.53, for a total transaction of $4,867,172.31. Following the completion of the sale, the insider owned 149,078 shares in the company, valued at approximately $24,825,959.34. This trade represents a 16.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 500,215 shares of company stock valued at $86,658,774 in the last ninety days. 3.80% of the stock is currently owned by insiders.

Applied Optoelectronics Company Profile (Free Report)

Applied Optoelectronics, Inc develops and manufactures high-speed fiber-optic networking products designed to support the growing bandwidth demands of data centers, telecommunications carriers and internet content providers. The company’s core offerings include pluggable optical transceiver modules, transponders and optical components that enable data transmission at rates ranging from 1G to 400G. These products are used to facilitate long-haul, metro and intra-data center connectivity, addressing the need for scalable, low-latency and energy-efficient solutions in modern network infrastructures.

The company’s product portfolio spans small-form factor pluggable modules such as SFP+, QSFP+ and QSFP28 units, as well as more advanced form factors like CFP2 and OSFP for ultra-high-speed applications.

Further Reading Five stocks we like better than Applied Optoelectronics The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding AAOI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Applied Optoelectronics, Inc. (NASDAQ:AAOI – Free Report).

Receive News & Ratings for Applied Optoelectronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Optoelectronics and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmova Asset Management Americas Inc. Has $6.13 Million Stock Position in Ionis Pharmaceuticals, Inc. $IONS

NEXT HEADLINE »Andra AP fonden Boosts Position in GE Aerospace $GE

Posted by Defense World Staff on Jul 21st, 2026

Andar Capital Management HK Ltd grew its position in shares of Semtech Corporation (NASDAQ:SMTC – Free Report) by 3.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 196,000 shares of the semiconductor company’s stock after purchasing an additional 6,475 shares during the period. Semtech accounts for about 12.9% of Andar Capital Management HK Ltd’s investment portfolio, making the stock its 3rd largest position. Andar Capital Management HK Ltd owned about 0.21% of Semtech worth $15,070,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Jones Financial Companies Lllp increased its stake in Semtech by 12,214.3% in the first quarter. Jones Financial Companies Lllp now owns 2,586 shares of the semiconductor company’s stock valued at $89,000 after purchasing an additional 2,565 shares during the last quarter. Empowered Funds LLC boosted its stake in Semtech by 11.5% in the 1st quarter. Empowered Funds LLC now owns 9,389 shares of the semiconductor company’s stock worth $323,000 after buying an additional 968 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Semtech by 5.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 411,814 shares of the semiconductor company’s stock worth $14,166,000 after buying an additional 22,629 shares during the last quarter. Strs Ohio purchased a new stake in Semtech in the 1st quarter valued at about $65,000. Finally, Cetera Investment Advisers purchased a new stake in Semtech in the 2nd quarter valued at about $226,000.

Semtech Price Performance Shares of NASDAQ SMTC opened at $125.88 on Tuesday. The company has a debt-to-equity ratio of 0.86, a current ratio of 2.37 and a quick ratio of 1.62. Semtech Corporation has a 1-year low of $46.02 and a 1-year high of $177.35. The company has a market capitalization of $11.73 billion, a price-to-earnings ratio of -322.77 and a beta of 2.31. The business has a 50-day moving average of $149.26 and a 200-day moving average of $109.07.

Semtech (NASDAQ:SMTC – Get Free Report) last posted its quarterly earnings data on Tuesday, May 26th. The semiconductor company reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.06. Semtech had a negative net margin of 3.05% and a positive return on equity of 18.31%. The company had revenue of $291.02 million during the quarter, compared to analysts’ expectations of $283.53 million. During the same period in the prior year, the company posted $0.38 EPS. The firm’s revenue for the quarter was up 15.9% on a year-over-year basis. Semtech has set its Q2 2027 guidance at 0.590-0.630 EPS. On average, equities analysts anticipate that Semtech Corporation will post 1.81 EPS for the current fiscal year.

Analyst Ratings Changes SMTC has been the topic of several recent analyst reports. Craig Hallum increased their price objective on shares of Semtech from $105.00 to $205.00 and gave the stock a “buy” rating in a report on Wednesday, May 27th. B. Riley Financial boosted their target price on shares of Semtech from $165.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday, May 27th. Susquehanna upped their price target on shares of Semtech from $170.00 to $200.00 and gave the stock a “positive” rating in a research report on Wednesday, May 27th. Needham & Company LLC reaffirmed a “buy” rating and set a $200.00 price target on shares of Semtech in a research note on Monday, July 13th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Semtech in a report on Thursday, June 18th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $189.07.

View Our Latest Report on SMTC

Insider Buying and Selling at Semtech In related news, insider John Michael Wilson sold 5,500 shares of the company’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $170.00, for a total transaction of $935,000.00. Following the completion of the transaction, the insider directly owned 80,876 shares in the company, valued at $13,748,920. This represents a 6.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Mark Lin sold 970 shares of the company’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $150.41, for a total transaction of $145,897.70. Following the transaction, the chief financial officer owned 34,896 shares of the company’s stock, valued at $5,248,707.36. This represents a 2.70% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 22,734 shares of company stock valued at $3,256,056. Corporate insiders own 0.44% of the company’s stock.

Semtech Company Profile (Free Report)

Semtech Corporation is a leading supplier of high-performance analog and mixed-signal semiconductors and advanced algorithms. The company’s products address a broad range of applications in the Internet of Things (IoT), data center and telecom, industrial, home automation, automotive, and aerospace markets. Semtech’s portfolio includes power management, signal integrity, protection devices, wireless and sensing technologies that enable smarter, more connected systems worldwide.

A core offering from Semtech is its LoRa® technology, a low-power, long-range wireless communication platform that has become a de facto standard for global IoT deployments.

See Also Five stocks we like better than Semtech The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Semtech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semtech and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINENutrien Ltd. $NTR Shares Purchased by Amova Asset Management Americas Inc.

NEXT HEADLINE »Heico Corporation $HEI Shares Bought by Amova Asset Management Americas Inc.

Ping An Unveils Innovative AI Solutions in Healthcare, Insurance and Payments at WAIC 2026 PR Newswire HONG KONG

Posted by Defense World Staff on Jul 21st, 2026

Allspring Global Investments Holdings LLC boosted its stake in Manulife Financial Corp (NYSE:MFC – Free Report) (TSE:MFC) by 8.2% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 687,432 shares of the financial services provider’s stock after buying an additional 52,020 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Manulife Financial were worth $23,909,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Basepoint Wealth LLC acquired a new position in shares of Manulife Financial during the 4th quarter valued at $25,000. Hantz Financial Services Inc. bought a new position in Manulife Financial during the fourth quarter valued at about $28,000. Sfam LLC acquired a new position in Manulife Financial during the fourth quarter worth about $28,000. Heritage Wealth Advisors acquired a new position in Manulife Financial during the fourth quarter worth about $30,000. Finally, Farmers & Merchants Trust Co of Chambersburg PA bought a new stake in Manulife Financial in the first quarter worth about $29,000. 52.56% of the stock is currently owned by institutional investors.

Manulife Financial Stock Down 2.1% Shares of NYSE MFC opened at $42.48 on Tuesday. Manulife Financial Corp has a 12 month low of $29.70 and a 12 month high of $43.56. The company has a market cap of $70.60 billion, a price-to-earnings ratio of 16.86 and a beta of 0.84. The business has a fifty day simple moving average of $39.98 and a 200-day simple moving average of $37.77.

Manulife Financial (NYSE:MFC – Get Free Report) (TSE:MFC) last issued its quarterly earnings results on Wednesday, May 13th. The financial services provider reported $0.77 earnings per share for the quarter, missing analysts’ consensus estimates of $0.79 by ($0.02). Manulife Financial had a return on equity of 16.58% and a net margin of 10.19%.The company had revenue of $8.89 billion during the quarter, compared to analysts’ expectations of $2.32 billion. During the same period in the prior year, the business posted $0.99 EPS. As a group, sell-side analysts expect that Manulife Financial Corp will post 3.03 EPS for the current fiscal year.

Manulife Financial Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Friday, June 19th. Investors of record on Friday, May 29th were given a $0.485 dividend. This represents a $1.94 annualized dividend and a dividend yield of 4.6%. The ex-dividend date was Friday, May 29th. Manulife Financial’s dividend payout ratio is 56.75%.

Analyst Ratings Changes A number of equities research analysts have weighed in on MFC shares. TD Securities reissued a “buy” rating on shares of Manulife Financial in a report on Thursday, May 14th. Zacks Research cut shares of Manulife Financial from a “hold” rating to a “strong sell” rating in a research note on Wednesday, July 15th. Scotiabank reiterated an “outperform” rating on shares of Manulife Financial in a report on Wednesday, July 15th. Finally, Weiss Ratings raised shares of Manulife Financial from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $51.50.

View Our Latest Stock Analysis on MFC

Manulife Financial Profile (Free Report)

Manulife Financial Corporation is a multinational insurance and financial services company headquartered in Toronto, Ontario. Founded in the late 19th century as The Manufacturers Life Insurance Company, Manulife provides a broad range of financial products and services to individual and institutional clients. Its core businesses include life and health insurance, retirement and pension solutions, wealth and asset management, and group benefits.

In wealth and asset management, Manulife operates through Manulife Investment Management and offers mutual funds, segregated funds, institutional asset management, and retirement plan solutions.

Recommended Stories Five stocks we like better than Manulife Financial The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding MFC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Manulife Financial Corp (NYSE:MFC – Free Report) (TSE:MFC).

Receive News & Ratings for Manulife Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Manulife Financial and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEEnovis Corporation $ENOV Shares Bought by Allspring Global Investments Holdings LLC

NEXT HEADLINE »Allspring Global Investments Holdings LLC Sells 19,057 Shares of DTE Energy Company $DTE

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. increased its position in shares of CoreWeave Inc. (NASDAQ:CRWV – Free Report) by 28.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,123,843 shares of the company’s stock after acquiring an additional 247,470 shares during the period. CoreWeave comprises about 1.2% of Amova Asset Management Americas Inc.’s portfolio, making the stock its 27th biggest position. Amova Asset Management Americas Inc. owned about 0.25% of CoreWeave worth $86,997,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of CoreWeave by 275.6% in the fourth quarter. Vanguard Group Inc. now owns 27,920,979 shares of the company’s stock worth $1,999,421,000 after purchasing an additional 20,487,478 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in CoreWeave by 6,022.0% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 112,768 shares of the company’s stock worth $8,075,000 after acquiring an additional 110,926 shares during the last quarter. Legal & General Group Plc raised its holdings in shares of CoreWeave by 8,455.6% in the 4th quarter. Legal & General Group Plc now owns 611,301 shares of the company’s stock valued at $43,775,000 after acquiring an additional 604,156 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of CoreWeave by 67.2% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 66,947 shares of the company’s stock valued at $4,794,000 after acquiring an additional 26,907 shares in the last quarter. Finally, Broad Peak Investment Advisers Pte Ltd bought a new stake in shares of CoreWeave during the 4th quarter valued at about $15,539,000.

Insider Transactions at CoreWeave In other news, major shareholder Magnetar Financial Llc sold 1,284,876 shares of the stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $119.91, for a total transaction of $154,069,481.16. Following the completion of the sale, the insider directly owned 264,061 shares in the company, valued at approximately $31,663,554.51. This represents a 82.95% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jack D. Cogen sold 986,540 shares of the business’s stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $107.80, for a total value of $106,349,012.00. The SEC filing for this sale provides additional information. Insiders sold 19,885,161 shares of company stock worth $2,326,801,573 in the last 90 days. Corporate insiders own 24.20% of the company’s stock.

CoreWeave Trading Down 0.2% Shares of CRWV stock opened at $73.06 on Tuesday. The business has a 50-day moving average of $99.55 and a 200 day moving average of $95.33. The company has a debt-to-equity ratio of 3.68, a current ratio of 0.31 and a quick ratio of 0.31. CoreWeave Inc. has a 1-year low of $63.80 and a 1-year high of $153.20. The stock has a market capitalization of $32.70 billion, a PE ratio of -23.49 and a beta of 7.17.

CoreWeave (NASDAQ:CRWV – Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($1.40) earnings per share for the quarter, missing the consensus estimate of ($1.17) by ($0.23). CoreWeave had a negative net margin of 25.57% and a negative return on equity of 43.07%. The company had revenue of $2.08 billion during the quarter. During the same period in the prior year, the firm earned ($0.60) EPS. The business’s revenue was up 111.6% on a year-over-year basis. As a group, sell-side analysts anticipate that CoreWeave Inc. will post -4.57 earnings per share for the current year.

Analysts Set New Price Targets A number of brokerages recently weighed in on CRWV. DA Davidson reaffirmed a “neutral” rating and issued a $100.00 target price (down from $175.00) on shares of CoreWeave in a research note on Monday, May 18th. Truist Financial raised their price objective on shares of CoreWeave from $85.00 to $131.00 and gave the company a “hold” rating in a research report on Friday, May 8th. Jefferies Financial Group lifted their price objective on shares of CoreWeave from $120.00 to $160.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Weiss Ratings upgraded shares of CoreWeave from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, June 24th. Finally, Barclays increased their target price on CoreWeave from $106.00 to $120.00 and gave the company an “equal weight” rating in a research note on Monday, May 11th. Twenty equities research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $138.87.

View Our Latest Stock Report on CoreWeave

CoreWeave Profile (Free Report)

CoreWeave is a U.S.-based provider of GPU-accelerated cloud infrastructure designed to support compute-intensive workloads such as artificial intelligence, machine learning, visual effects rendering and other high-performance computing applications. The company supplies access to large fleets of modern GPUs and complementary infrastructure that enable customers to train and deploy large models, run inference at scale, and process graphics-heavy workloads with low latency and high throughput.

CoreWeave’s product offering includes on-demand and dedicated GPU instances, bare-metal servers, private clusters and managed services tailored for enterprise and developer use.

Featured Articles Five stocks we like better than CoreWeave The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding CRWV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CoreWeave Inc. (NASDAQ:CRWV – Free Report).

Receive News & Ratings for CoreWeave Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CoreWeave and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmova Asset Management Americas Inc. Has $84.69 Million Stake in Natera, Inc. $NTRA

NEXT HEADLINE »Amova Asset Management Americas Inc. Decreases Stake in Kratos Defense & Security Solutions, Inc. $KTOS

Posted by Defense World Staff on Jul 21st, 2026

Allspring Global Investments Holdings LLC bought a new stake in Circle Internet Group, Inc. (NYSE:CRCL – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 239,821 shares of the company’s stock, valued at approximately $21,761,000. Allspring Global Investments Holdings LLC owned 0.10% of Circle Internet Group at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC acquired a new stake in Circle Internet Group during the 2nd quarter valued at approximately $27,000. Larson Financial Group LLC lifted its position in Circle Internet Group by 3,800.0% during the third quarter. Larson Financial Group LLC now owns 195 shares of the company’s stock valued at $26,000 after purchasing an additional 190 shares during the period. Harbour Investments Inc. lifted its position in Circle Internet Group by 170.0% during the fourth quarter. Harbour Investments Inc. now owns 378 shares of the company’s stock valued at $30,000 after purchasing an additional 238 shares during the period. National Bank of Canada FI purchased a new stake in Circle Internet Group in the third quarter valued at $37,000. Finally, Federation des caisses Desjardins du Quebec boosted its holdings in Circle Internet Group by 5.4% in the fourth quarter. Federation des caisses Desjardins du Quebec now owns 5,391 shares of the company’s stock valued at $428,000 after purchasing an additional 278 shares during the last quarter.

Circle Internet Group Trading Up 8.1% Shares of CRCL stock opened at $65.34 on Tuesday. Circle Internet Group, Inc. has a 12-month low of $49.90 and a 12-month high of $231.88. The business’s 50 day moving average is $85.44 and its two-hundred day moving average is $87.76. The company has a market capitalization of $16.24 billion and a P/E ratio of -20.42.

Circle Internet Group (NYSE:CRCL – Get Free Report) last posted its quarterly earnings data on Monday, May 11th. The company reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.06). Circle Internet Group had a negative net margin of 2.76% and a positive return on equity of 2.89%. The business had revenue of $694.13 million during the quarter. Circle Internet Group’s revenue was up 20.0% compared to the same quarter last year. On average, research analysts predict that Circle Internet Group, Inc. will post 0.98 earnings per share for the current fiscal year.

Analyst Ratings Changes CRCL has been the subject of a number of recent research reports. Freedom Capital upgraded Circle Internet Group to a “hold” rating in a research note on Tuesday, April 21st. Wall Street Zen downgraded Circle Internet Group from a “hold” rating to a “sell” rating in a research note on Saturday, April 11th. Compass Point set a $62.00 target price on Circle Internet Group in a report on Wednesday, July 15th. Wells Fargo & Company lifted their price target on Circle Internet Group from $111.00 to $142.00 and gave the company an “overweight” rating in a research report on Tuesday, May 5th. Finally, Needham & Company LLC upped their price objective on Circle Internet Group from $130.00 to $150.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, twelve have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, Circle Internet Group has an average rating of “Hold” and an average price target of $113.25.

Check Out Our Latest Stock Analysis on Circle Internet Group

Insider Transactions at Circle Internet Group In other news, Director Patrick Sean Neville sold 1,034,396 shares of the firm’s stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $82.87, for a total value of $85,720,396.52. Following the transaction, the director owned 2,018 shares in the company, valued at $167,231.66. This trade represents a 99.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Hossein Razzaghi sold 34,623 shares of the firm’s stock in a transaction that occurred on Wednesday, June 10th. The shares were sold at an average price of $78.85, for a total value of $2,730,023.55. Following the completion of the transaction, the insider owned 666,404 shares in the company, valued at approximately $52,545,955.40. This trade represents a 4.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,956,527 shares of company stock worth $155,711,921 in the last three months. 10.85% of the stock is owned by corporate insiders.

Circle Internet Group Company Profile (Free Report)

Circle Internet Group (NYSE: CRCL) is a financial technology company that builds infrastructure to enable businesses and developers to use and move money on public blockchains. Co-founded by Jeremy Allaire and Sean Neville, the company is best known as a principal issuer and steward of USDC, a dollar-pegged stablecoin developed through the CENTRE Consortium, which Circle co-founded with Coinbase. Jeremy Allaire serves as CEO and has been a visible leader in the company’s strategy and public engagement around digital currency and payments innovation.

Circle’s core products and services center on digital currency issuance and programmable payments.

Read More Five stocks we like better than Circle Internet Group The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Circle Internet Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Circle Internet Group and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAllspring Global Investments Holdings LLC Sells 38,930 Shares of People Incorporated Common Stock $PPLI

NEXT HEADLINE »Allspring Global Investments Holdings LLC Has $21.26 Million Position in ITT Inc. $ITT

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. increased its stake in Figma, Inc. (NYSE:FIG – Free Report) by 641.4% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,467,887 shares of the company’s stock after acquiring an additional 1,269,900 shares during the quarter. Amova Asset Management Americas Inc. owned approximately 0.33% of Figma worth $31,031,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Parallel Advisors LLC lifted its holdings in shares of Figma by 3,890.0% during the first quarter. Parallel Advisors LLC now owns 1,197 shares of the company’s stock valued at $25,000 after purchasing an additional 1,167 shares during the last quarter. NewEdge Advisors LLC acquired a new stake in Figma during the 3rd quarter worth about $26,000. DV Equities LLC acquired a new stake in Figma during the 4th quarter worth about $26,000. Concord Wealth Partners lifted its stake in Figma by 1,446.8% during the fourth quarter. Concord Wealth Partners now owns 727 shares of the company’s stock valued at $27,000 after buying an additional 680 shares in the last quarter. Finally, Harbour Investments Inc. boosted its holdings in shares of Figma by 1,568.2% in the fourth quarter. Harbour Investments Inc. now owns 734 shares of the company’s stock worth $27,000 after buying an additional 690 shares during the period.

Figma Trading Up 0.5% FIG opened at $24.06 on Tuesday. The stock has a fifty day moving average price of $21.28 and a 200 day moving average price of $23.85. Figma, Inc. has a 1 year low of $16.60 and a 1 year high of $142.92. The stock has a market cap of $10.72 billion and a price-to-earnings ratio of -7.02.

Figma (NYSE:FIG – Get Free Report) last issued its earnings results on Thursday, May 14th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of ($0.17) by $0.27. The company had revenue of $333.44 million for the quarter. Figma had a negative return on equity of 98.51% and a negative net margin of 123.83%.The firm’s quarterly revenue was up 46.1% on a year-over-year basis. As a group, sell-side analysts forecast that Figma, Inc. will post -0.79 earnings per share for the current fiscal year.

Insider Transactions at Figma In other Figma news, CFO Praveer Melwani sold 30,460 shares of the business’s stock in a transaction that occurred on Monday, July 6th. The shares were sold at an average price of $20.48, for a total value of $623,820.80. Following the completion of the sale, the chief financial officer directly owned 1,711,526 shares of the company’s stock, valued at $35,052,052.48. The trade was a 1.75% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Dylan Field sold 174,430 shares of the firm’s stock in a transaction on Friday, May 29th. The shares were sold at an average price of $25.02, for a total transaction of $4,364,238.60. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 733,309 shares of company stock valued at $17,824,756. Insiders own 32.26% of the company’s stock.

Analysts Set New Price Targets A number of equities research analysts have recently issued reports on FIG shares. Wells Fargo & Company cut their price target on shares of Figma from $42.00 to $36.00 and set an “overweight” rating on the stock in a report on Friday, June 26th. Piper Sandler reissued an “overweight” rating and set a $30.00 target price on shares of Figma in a research note on Thursday, June 25th. Stifel Nicolaus set a $25.00 target price on Figma in a report on Friday, May 15th. BTIG Research began coverage on Figma in a research note on Monday, April 13th. They issued a “neutral” rating for the company. Finally, Oppenheimer restated a “market perform” rating on shares of Figma in a report on Thursday, June 25th. Five analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $32.67.

Read Our Latest Stock Report on Figma

Figma Profile (Free Report)

Figma is a San Francisco–based software company that offers a web-based platform for interface design, prototyping and collaboration. Its flagship product, Figma, enables teams to create and refine user interfaces, vector graphics and design systems directly in a browser, eliminating the need for local installations. The platform’s real-time collaboration features allow multiple stakeholders—designers, developers and product managers—to edit and comment simultaneously, streamlining workflows and reducing version control issues.

In addition to its core design tool, Figma provides FigJam, a digital whiteboarding solution that facilitates brainstorming sessions, wireframing and diagramming.

Recommended Stories Five stocks we like better than Figma The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Figma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Figma and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAlTi Global Inc. Makes New $2.37 Million Investment in Investar Holding Corporation $ISTR

NEXT HEADLINE »Amova Asset Management Americas Inc. Reduces Stake in Intellia Therapeutics, Inc. $NTLA

Apple will report its Q3 on Thursday, July 30. Ahead of the release, shares are trading at new highs and at a forward multiple of just under 40x earnings. The company also just regained its throne as the world's largest from Nvidia.

As strange as it sounds. Tesla's earnings aren't that important on its second-quarter earnings report.

Boeing and Airbus are starting to map out the next generation of narrow-body aircraft, but the world's two dominant planemakers say their airline customers are more concerned with getting today's jets delivered than pressing for all-new models.

Boeing CEO Kelly Ortberg said Monday that the company still needs "a couple more years" to put its finances in a position to support a new commercial aircraft program. 

Airbus CEO Guillaume Faury, meanwhile, said the European manufacturer is targeting the launch of a next-generation single-aisle program around 2030, with entry into service in the second half of the following decade.

While the two CEOs struck different tones, they pointed to broadly similar timeframes.

Airbus has publicly attached a target year to launch its next aircraft. Boeing is indicating that it could be financially capable of moving on a similar horizon, while preserving the option to wait if the technology or market case is not strong enough.

"We think about three things that have to happen," Ortberg told CNBC's Phil LeBeau. "First of all, we have to be ready, and part of that is getting our financial house in order, and we're working on that. It's going to take a couple more years to get where we want to be."

watch now

The technology also has to be ready, he said, and airline customers must be ready to move on from Boeing's current product line.

"The market's got to be ready. Right now, the customers are telling me, 'focus on your existing product line, we really want to see better maturity of the existing product line before we move to a new airplane.'"

It comes as aircraft manufacturers experience persistent production bottlenecks across the industry. Boeing is trying to increase 737 Max output and is still reeling from a series of production and quality issues and a near-catastrophic blowout of a fuselage door plug in January 2024.

Airbus has said engine availability, particularly from Pratt & Whitney, forced it to adjust production plans for this year and next, although Faury said the situation had stabilized.

Faury said Airbus is focused on ramping production and delivering aircraft already on order even as it prepares its next generation of commercial aircraft.

"We're a long-term industry," Faury said. "It takes time to prepare the technologies, to launch a program for the product, for the production system, [to] enter into service with the certification, do the ramp up."

watch now

Faury said Airbus is preparing its next-generation single-aisle aircraft and wants to maintain its lead in that market. The company is targeting a program launch around 2030 and entry into service in the second half of the 2030s.

For both manufacturers, however, increasing production and delivering existing orders remain the more immediate tasks.

Aircraft deliveries in focusRBC Capital Markets analysts said last week that investors are focused on Boeing's ability to increase production of the 737 Max and 787, complete certification of the Max 7 and Max 10, improve margins, and generate cash.

"The primary focus for investors will remain on the state of the supply chain and delivery schedules," the analysts wrote in a note to clients.

The same appears to be true for Airbus. RBC said investors were looking for a clearer path to Airbus's A320 and A350 production goals after the company's stronger second-quarter deliveries boosted confidence in its full-year target.

Airbus has a backlog of over 9,000 aircraft, and demand continues to outpace available supply. Airbus booked 51 A320neo orders in June, while second-quarter delivery growth was driven almost entirely by the A320 family, according to Jefferies analysts.

Jefferies said Airbus's growing delivery volume of A320-family aircraft – 190 in the second quarter – is expected to drive a significant improvement in earnings. Airbus reports deliveries on a monthly basis and will publish its quarterly earnings report next week.

At Boeing, the focus remains on completing the current 737 Max family.

Jefferies said on Sunday that certification work on the 737 Max-7 and Max-10 was 95% and 98% complete, respectively. The Max-10 had 1,533 aircraft on order, accounting for roughly a third of Boeing's 737 backlog.

Ortberg said on Monday that the 737 Max-7 certification with the FAA is expected "very shortly" and would mark a critical milestone, as it would be the first new airplane the FAA has certified in a long time. 

Boeing has also invested about $1 billion in a fourth 737 Max production line in Everett, Washington, which will eventually allow the company to raise production beyond the capacity of its three existing Renton lines.

That suggests investors and airline customers are broadly aligned: both want the manufacturers to execute on the aircraft already promised.

While both Boeing and Airbus work through large order backlogs and production constraints, airlines continue to add capacity using existing aircraft models.

Ryanair, Boeing's largest customer outside of the U.S., Chief Financial Officer Neil Sorahan said Monday that the delivery of the last aircraft in its current order of Boeing 737 Max 8-200 jets helped Ryanair expand its fleet to just under 650 aircraft and grow first-quarter traffic by 6%.

The airline expects passenger numbers to grow about 4% this year to 216 million, Sorahan told CNBC's "Squawk Box."

watch now

While neither manufacturer appears to be under intense pressure from customers to move faster, work on the next-generation aircraft continues. 

The eventual successors to Boeing's 737 Max and Airbus' A320neo families may shape competition in the industry's largest commercial aircraft market for decades. But before Boeing and Airbus compete over tomorrow's narrow-body aircraft, both still have to deliver on today's orders.